These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 27148831

  • 1. Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication.
    King AJ, Rotchford AP.
    JAMA Ophthalmol; 2016 Jul 01; 134(7):742-7. PubMed ID: 27148831
    [Abstract] [Full Text] [Related]

  • 2. Monocular trial of intraocular pressure-lowering medication: a prospective study.
    King AJ, Uppal S, Rotchford AP, Lakshumanan A, Abedin A, Henry E.
    Ophthalmology; 2011 Nov 01; 118(11):2190-5. PubMed ID: 21724262
    [Abstract] [Full Text] [Related]

  • 3. Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension.
    Sarkisian SR, Ang RE, Lee AM, Berdahl JP, Heersink SB, Burden JH, Doan LV, Stephens KG, Kothe AC, Usner DW, Katz LJ, Navratil T, GC-010 Travoprost Intraocular Implant Investigators.
    Ophthalmology; 2024 Sep 01; 131(9):1021-1032. PubMed ID: 38423216
    [Abstract] [Full Text] [Related]

  • 4. A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma.
    Realini TD.
    Ophthalmology; 2009 Jul 01; 116(7):1237-42. PubMed ID: 19576495
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
    Lopes JF, Hubatsch DA, Amaris P.
    BMC Ophthalmol; 2015 Nov 12; 15():166. PubMed ID: 26563363
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes.
    Liu JH, Realini T, Weinreb RN.
    Ophthalmology; 2011 Oct 12; 118(10):1995-2000. PubMed ID: 21676464
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucoma.
    Gandolfi S, Paredes T, Goldberg I, Coote M, Wells A, Volksone L, Pillai MR, Stalmans I, Denis P, Travoprost Bak-Free Clinical Study Group.
    Eur J Ophthalmol; 2012 Oct 12; 22(1):34-44. PubMed ID: 22167541
    [Abstract] [Full Text] [Related]

  • 16. Concordance of diurnal intraocular pressure between fellow eyes in primary open-angle glaucoma.
    Dinn RB, Zimmerman MB, Shuba LM, Doan AP, Maley MK, Greenlee EC, Alward WL, Kwon YH.
    Ophthalmology; 2007 May 12; 114(5):915-20. PubMed ID: 17467528
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of continuous 24-hour intraocular pressure monitoring for assessment of prostaglandin-induced pressure reduction in glaucoma.
    Holló G, Kóthy P, Vargha P.
    J Glaucoma; 2014 Jan 12; 23(1):e6-12. PubMed ID: 24370812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.